Tech Company Financing Transactions
Curve Therapeutics Funding Round
Curve Therapeutics closed a $51.4 million Series A funding round on 2/27/2024. Investors included Pfizer Venture Investments, Advent Life Sciences and British Patient Capital.
Transaction Overview
Company Name
Announced On
2/27/2024
Transaction Type
Venture Equity
Amount
$51,420,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to progress development of these assets rapidly towards clinical development and to expand the discovery platform beyond challenging and complex intracellular protein targets.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Delta House Enterprise Road Southampton Science Park
Southampton, SO16 7NS
UK
Southampton, SO16 7NS
UK
Phone
Undisclosed
Website
Email Address
Overview
Our mission is to unlock the therapeutic potential of complex and challenging disease targets that are intractable to conventional discovery methods. We achieve this by using our innovative discovery platform to identify functional Microcycles that modulate targets within their native intracellular environment.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Simon Kerry
Chief Scientific Officer
Ali Tavassoli
Vice President
Monika Ermann
Vice President
Sally Price
VP - Finance
Julia Jones
Browse more venture capital transactions:
Prev: 2/27/2024: Enkrypt AI venture capital transaction
Next: 2/27/2024: QED venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs